Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial

Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The site's footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:50:17.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A sitewide notice says NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    0.9%
    Check dated 2026-10-25T15:17:58.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T15:10:30.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T15:19:17.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study record history now shows a new revision labeled v3.7.0, replacing the previous v3.6.6 entry.
    Difference
    0.1%
    Check dated 2026-09-20T20:25:27.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The record history shows a new revision entry v3.6.6 added and the previous revision v3.6.5 removed, indicating a metadata update to the study's version history.
    Difference
    0.1%
    Check dated 2026-08-30T21:37:50.000Z thumbnail image

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.